Lazard Asset Management
GOSS icon

Lazard Asset Management’s Gossamer Bio GOSS Stock Holding History

Lazard Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-708
Closed -$176K – 1953
2025
Q4 		$176K Buy
708
+187
+36% +$42.7K ﹤0.01% 1673
2025
Q3 		$110K Sell
521
-321
-38% -$56.6K ﹤0.01% 1678
2025
Q2 		$82K Buy
842
+295
+54% +$25.7K ﹤0.01% 1907
2025
Q1 		$48K Sell
547
-796
-59% -$73.6K ﹤0.01% 2001
2024
Q4 		$97K Buy
1,343
+1,326
+7,800% +$90.9K ﹤0.01% 1802
2024
Q3 		$1K Buy
+17
New +$1.31K ﹤0.01% 2156
2023
Q3 		– Sell
-1
Closed – – 2350
2023
Q2 		$0 Hold
1
– – ﹤0.01% 2394
2023
Q1 		$0 Sell
1
-130
-99% -$19.9K ﹤0.01% 2402
2022
Q4 		$22K Sell
131
-199
-60% -$131K ﹤0.01% 2118
2022
Q3 		$316K Hold
330
– – ﹤0.01% 1174
2022
Q2 		$221K Sell
330
-225
-41% -$139K ﹤0.01% 1259
2022
Q1 		$385K Hold
555
– – ﹤0.01% 1144
2021
Q4 		$501K Buy
+555
New +$527K ﹤0.01% 1100
2021
Q1 		– Sell
-386
Closed -$298K – 1914
2020
Q4 		$298K Buy
+386
New +$304K ﹤0.01% 1050

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Lazard Asset Management's GOSS Position: Q1 2026 in Review

Lazard Asset Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 708 shares — an estimated $176K sold.

Lazard Asset Management first reported a position in GOSS in Q4 2020 and held it in 14 quarters. The position peaked at $501K in Q4 2021. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Lazard Asset Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 708 Gossamer Bio shares in Q1 2026, an estimated $176K.
  • Lazard Asset Management first reported a position in Gossamer Bio in Q4 2020 and held it in 14 quarters.
  • Lazard Asset Management's Gossamer Bio position peaked at $501K in Q4 2021.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.